| Gene symbol | H19 | Synonyms | ASM, ASM1, BWS, D11S813E, LINC00008, MIR675HG, NCRNA00008, WT2 | Type of gene | ncRNA |
| Chromosome | 11 | Map location | 11p15.5 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | H19 imprinted maternally expressed transcript | ||||
| Gene symbol | IGF1R | Synonyms | CD221, IGFIR, IGFR, JTK13 | Type of gene | protein-coding |
| Chromosome | 15 | Map location | 15q26.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | insulin like growth factor 1 receptor | ||||
| GTO ID | GTC2601 |
| Trial ID | NCT04767750 |
| Disease | Cancer | Type 2 Diabetes | Hepatocellular Carcinoma |
| Altered gene | H19|IGF1R |
| Therapeutic/Target gene | Therapeutic gene|Target gene |
| Therapy | lncRNA |
| Recruitment status | Completed |
| Title | Role of LncRNA H19 in The Regulation of IGF-1R Expression: A Possible Association Between Type 2 Diabetes and Hepatocellular Carcinoma |
| Year | 2020 |
| Country | Egypt |
| Company sponsor | Mansoura University |
| Other ID(s) | MS.20.10.26 |
| Cohort1: HCC patients | |||||
|
|||||
| Cohort2: T2DM patients | |||||
|
|||||
| Cohort3: HCC & T2DM patients | |||||
|
|||||
| Cohort4: Controls | |||||
|
|||||